Correlation between serum serotonin and endoscopy inflammation scores in patients with ileal pouches

Journal of Crohn's and Colitis

Volumn 7, Issue 4, 2013, Pages

  Wang, Yinghong ^a   Gong, Hua ^b   Lopez, Rocio ^a   Lian, Lei ^a   Kiran, Ravi P ^a   Soffer, Edy E ^c   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Prometheus Laboratories   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Ileal pouch; Inflammatory bowel disease; Restorative proctocolectomy; Serotonin; Ulcerative colitis

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; CROHN DISEASE; DEMOGRAPHY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; ENDOSCOPY; ENTERITIS; FEMALE; HUMAN; ILEAL POUCH ANAL ANASTOMOSIS; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM POUCH; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROSPECTIVE STUDY; SEROTONIN BLOOD LEVEL; SMOKING; SYMPTOM;

ADULT; BIOLOGICAL MARKERS; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEROTONIN; SEVERITY OF ILLNESS INDEX;

EID: 84875274933     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.07.028     Document Type: Article

References (44)

1. Camilleri M., Atanasova E., Carlson P.J., Ahmad U., Kim H.J., Viramontes B.E., et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002, 123:425-432.
2. Spiller R.C., Jenkins D., Thornley J.P., Hebden J.M., Wright T., Skinner M., et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47:804-811.
3. Chadwick V.S., Chen W., Shu D., Paulus B., Bethwaite P., Tie A., et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122:1778-1783.
4. Dunlop S.P., Jenkins D., Neal K.R., Spiller R.C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003, 125:1651-1659.
5. Bearcroft C.P., Perrett D., Farthing M.J. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998, 42:42-46.
6. Houghton L.A., Atkinson W., Whitaker R.P., Whorwell P.J., Rimmer M.J. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003, 52:663-670.
7. Atkinson W., Lockhart S., Whorwell P.J., Keevil B., Houghton L.A. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006, 130:34-43.
8. Minderhoud I.M., Oldenburg B., Schipper M.E., ter Linde J.J., Samsom M. Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin Gastroenterol Hepatol 2007, 5:714-720.
9. Isgar B., Harman M., Kaye M.D., Whorwell P.J. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983, 24:190-192.
10. Oshima S., Fujimura M., Fukimiya M. Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem Cell Biol 1999, 112:257-263.
11. Linden D.R., Chen J.X., Gershon M.D., Sharkey K.A., Mawe G.M. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003, 285:G207-G216.
12. Shen B., Achkar J.P., Lashner B.A., Ormsby A.H., Remzi F.H., Bevins C.L., et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121:261-267.
13. Shen B., Achkar J.P., Lashner B.A., Ormsby A.H., Brzezinski A., Soffer E.E., et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002, 97:972-977.
14. Shen B., Sanmiguel C., Bennett A.E., Lian L., Larive B., Remzi F.H., et al. Irritable pouch syndrome is characterized by visceral hypersensitivity. Inflamm Bowel Dis 2010, 17:994-1002.
15. Shen B., Liu W., Remzi F.H., Shao Z., Lu H., DeLaMotte C., et al. Enterochromaffin cell hyperplasia in irritable pouch syndrome. Am J Gastroenterol 2008, 103:2293-2300.
16. Shen B., Achkar J.P., Connor J.T., Ormsby A.H., Remzi F.H., Bevins C.L., et al. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003, 46:748-753.
17. Shen B., Fazio V.W., Remzi F.H., Brzezinski A., Bennett A.E., Lopez R., et al. Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2006, 4:81-89. [quiz 2-3].
18. Shen B., Fazio V.W., Remzi F.H., Delaney C.P., Bennett A.E., Achkar J.P., et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005, 100:93-101.
19. Shen B., Lashner B.A., Bennett A.E., Remzi F.H., Brzezinski A., Achkar J.P., et al. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol 2004, 99:1527-1531.
20. Shen B., Fazio V.W., Remzi F.H., Bennett A.E., Brzezinski A., Lopez R., et al. Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. Am J Gastroenterol 2006, 101:2760-2768.
21. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 2003, 63:453-461.
22. Simchuk E.J., Thirlby R.C. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000, 24:851-856.
23. Cloez-Tayarani I., Changeux J.P. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 2007, 81:599-606.
24. Soga F., Katoh N., Inoue T., Kishimoto S. Serotonin activates human monocytes and prevents apoptosis. J Invest Dermatol 2007, 127:1947-1955.
25. Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O'Brien S., O'Mahony L., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 2006, 130:304-311.
26. Liebregts T., Adam B., Bredack C., Roth A., Heinzel S., Lester S., et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-920.
27. Barkhordari E., Rezaei N., Ansaripour B., Larki P., Alighardashi M., Ahmadi-Ashtiani H.R., et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010, 30:74-79.
28. Kindt S., Van Oudenhove L., Broekaert D., Kasran A., Ceuppens J.L., Bossuyt X., et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009, 21:389-398.
29. Weston A.P., Biddle W.L., Bhatia P.S., Miner P.B. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38:1590-1595.
30. Guilarte M., Santos J., de Torres I., Alonso C., Vicario M., Ramos L., et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007, 56:203-209.
31. Barbara G., Wang B., Stanghellini V., de Giorgio R., Cremon C., Di Nardo G., et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132:26-37.
32. Santos J., Guilarte M., Alonso C., Malagelada J.R. Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol 2005, 40:129-140.
33. Houghton L.A., Atkinson W., Lockhart C., Whorwell P.J., Keevil B. Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine. Neurogastroenterol Motil 2007, 19:724-731.
34. Ahonen A., Kyosola K., Penttila O. Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann Clin Res 1976, 8:1-7.
35. Magro F., Vieira-Coelho M.A., Fraga S., Serrao M.P., Veloso F.T., Ribeiro T., et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci 2002, 47:216-224.
36. Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J., Blaszyk H., et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004, 126:1657-1664.
37. Bishop A.E., Pietroletti R., Taat C.W., Brummelkamp W.H., Polak J.M. Increased populations of endocrine cells in Crohn's ileitis. Virchows Arch A Pathol Anat Histopathol 1987, 410:391-396.
38. El-Salhy M., Danielsson A., Stenling R., Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 1997, 242:413-419.
39. Keohane J., O'Mahony C., O'Mahony L., O'Mahony S., Quigley E.M., Shanahan F. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?. Am J Gastroenterol 2010, 105. :1788, 1789-94. [quiz 1795].
40. O'Hara J.R., Skinn A.C., MacNaughton W.K., Sherman P.M., Sharkey K.A. Consequences of Citrobacter rodentium infection on enteroendocrine cells and the enteric nervous system in the mouse colon. Cell Microbiol 2006, 8:646-660.
41. O'Hara J.R., Ho W., Linden D.R., Mawe G.M., Sharkey K.A. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol 2004, 287:G998-G1007.
42. Wheatcroft J., Wakelin D., Smith A., Mahoney C.R., Mawe G., Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005, 17:863-870.
43. Linden D.R., Foley K.F., McQuoid C., Simpson J., Sharkey K.A., Mawe G.M. Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil 2005, 17:565-574.
44. Rubin D.C., Zhang H., Qian P., Lorenz R.G., Hutton K., Peters M.G. Altered enteroendocrine cell expression in T cell receptor alpha chain knock-out mice. Microsc Res Tech 2000, 51:112-120.